Advanced Search

Antimicrobials & Drug Resistance Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Keith Klugman

    Keith Klugman

    Department of International Health, Emory University, Atlanta, GA, USA

  • Photo of Ethan Rubinstein

    Ethan Rubinstein

    Section of Infectious Diseases, University of Manitoba, Winnipeg, Canada

Section Topics

  • » Infections & resistance mechanisms: bioterror agents & others
  • » Infections & resistance mechanisms: enterobacteriae
  • » Infections & resistance mechanisms: enterococci
  • » Infections & resistance mechanisms: meningococci
  • » Infections & resistance mechanisms: pneumococci
  • » Infections & resistance mechanisms: staphylococci
  • » Infections & resistance mechanisms: streptococci
  • » Infections & resistance mechanisms: tuberculosis
  • » Pharmacokinetics & pharmacodynamics
  • » Resistance & resistance mechanisms: betalactams
  • » Resistance & resistance mechanisms: fluroquinolones
  • » Resistance & resistance mechanisms: macrolides
  • » Resistance & resistance mechanisms: others
  • » Resistance to antifungals
  • » Resistance to antiparasites
  • » Resistance to antivirals
  • » Susceptibility testing
  • » Zoonotic infections

LATEST EVALUATION

This study in rhesus macaques demonstrates long-term persistence of viable Borrelia burgdorferi spirochetes despite aggressive antibiotic therapy. Undoubtedly, these data will be used to justify the controversial prescription by some physicians of extended antibiotic therapy...

Lyle Petersen, Centers for Disease Control and Prevention, USA. F1000 Neurological Disorders

6 Recommended

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria.

Takesue Y, Nakajima K, Ichiki K, Ishihara M, Wada Y, Takahashi Y, Tsuchida T, Ikeuchi H. J Hosp Infect. 2010 May; 75(1):28-32

1 Evaluation, most recent by

Mathias Pletz and Philipp Reuken, University Hospital Jena, Germany. F1000 Respiratory Disorders

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000